Depression

Treatment of Unipolar depression

Depression is a very common medical problem, prevalence is over 10% of the population. When patient has other medical symptoms such as headache, chest pain, shortness of breath, soft tissue pain, low energy, poor sleep, weakness, numbness, they will be seen by a variety of specialists and receive extensive testings and treatment.

If depression is not dealt with first, treatment of the other symptoms will has a low chance of improving.

Diagnosis

Depression: prevalence about 10%

  • 5 or more of the following, nearly every day for > 2weeks
    • Depressed mood
    • Loss of interest or pleasure in most activities
    • Insomnia or hypersomnia
    • Change in appetite or weight
    • Psychomotor retardation or agitation
    • Low energy
    • Poor concentration
    • Thoughts of worthlessness or guilt
    • Recurrent thoughts about death or suicide

Dysthymia

  • 2 or more of the following, for over 2 years
    • Decreased or increased appetite
    • Insomnia or hypersomnia
    • Low energy
    • Poor self-esteem
    • Poor concentration
    • Hopelessness

Screening

Treatment

ClassNameStartMaxNotes
SNRIDuloxetine (Cymbalta)30 mg qd60 mg qd
SNRIVenlafaxine XR (Effexor XR)75 mg qd150 mg qd
SNRIlevomilnacipran ER20 mg qdapproved, coming
SNRIMinacipran (Savella)25 mg bid100 mg bidexpensive $400/month
Serotonin modTrazadone100 mg hs300 mg hs
SNRI, SSRIallmay cause transient nausea
AtypicalBupropion sr100 mg bid200 mg bidmay cause insomnia
AtypicalMitrazapine (Remeron)15 mg hs45 mg hscause drowsiness, weight gain
SSRICitalopram (Celexa)10 mg qd40 mg qd
SSRIEscitalopram (Lexapro)10 mg qd20 mg qd
TricyclicAmitriptyline (Elavil)10 mg hscause drowsinss, anticholinergic, weight gain
TetracyclicDesipramine 25 mg hsless side effect than Amitruotyline
  • Start with single antidepressant
  • Chose drug based on safety and side effect profile
  • Single antidepressant resulted in remission 30-50% of patients
  • If not effective, switch to an antidepressant of a different class
  • If poor response consider
    • Mitrazapine plus ssri
    • Mitrazapine plus buproprion
    • Mitrazapine plus venlafaxine
    • SSRI plus nortriptyline
    • or add aripiprazole (Abilify) 2-15 mg per day
      • main side effect akathisia, dose dependent
  • Still resistant, or initial depression is severe, evaluate by psychiatrist

Clinical depression a graphical review:

Osmosis: a graphical review of depression

Depression: ssri and snri

Major depression and SSRI/SNRI

References